Comparing two imaging systems for inherited retinal disease
Part of Eyes & vision clinical trials.
This trial compares two different imaging systems (Clarus and Optos) to see how well they can capture images of the retina in people with inherited retinal diseases. The goal is to find which system works better for diagnosing and tracking these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with an inherited retinal disease (IRD) either by a doctor or by genetic testing.
- You do not have other serious eye conditions that could interfere with the imaging, such as advanced cataracts, corneal problems, uncontrolled eye movements, or bleeding in the eye.
- You do not have eye conditions that could affect how doctors interpret the images, such as scars on the retina or abnormal blood vessels under the retina.
- You are able to sit still and look at a fixed point for the imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special camera (OCT) to capture detailed images of the eye. It aims to improve eye disease detection. You may join if you have retinal disease, glaucoma, corneal disease, or healthy eyes.
This trial uses a special eye scanner to look at eye diseases. It might help doctors see eye problems more clearly.
This study aims to improve how we take pictures of the back of the eye (called OCT imaging) in both healthy adults and children. It will help doctors get better images to diagnose and manage eye conditions.
This trial studies a light-guided eye treatment in people with generalized inherited retinal disease (a genetic cause of vision loss). It aims to see whether the approach works safely and can improve function for people whose vision is already significantly reduced.
This study evaluates a new retinal imaging device (Intalight Dream OCTA) by comparing its images with standard eye imaging methods. If you have a retinal condition that requires imaging tests, this trial helps doctors understand how well the new technology works.
This trial is testing a new software tool that helps doctors see and assess different parts of the retina in eye scans. It aims to see how well the tool works in people with and without certain retina conditions.
Hear when a new Retinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.